FDA.reportPublic FDA data

Application 209942

Type
ANDA
Sponsor
TEVA PHARMS USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ALYQTADALAFILTABLET;ORAL20MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0093-3334ALYQTadalafilTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-3334ALYQTadalafilTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-3334ALYQTadalafilTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-3334ALYQTadalafilTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-3334ALYQTadalafilTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-3334ALYQTadalafilTeva Pharmaceuticals USA, Inc.ANDACurrent
42291-804ALYQTadalafilAvKARE, Inc.ANDACurrent
42291-804ALYQTadalafilAvKAREANDACurrent
42291-804ALYQTadalafilAvKAREANDACurrent